Nu Skin Enterprises, Inc. (NUS): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.03B
Year ended 2025-12-31
$951.49M
Trailing 12 months to 2026-06-30
-13.5%
3-year compound annual growth
-11.7%
5-year compound annual growth
-5.2%
10-year compound annual growth
$2.67B2008-12-31: $1.02B2009-12-31: $1.09B2010-12-31: $1.26B2011-12-31: $1.40B2012-12-31: $1.78B2013-12-31: $2.67B2014-12-31: $2.09B2015-12-31: $1.76B2016-12-31: $1.71B2017-12-31: $1.78B2018-12-31: $2.04B2019-12-31: $1.84B2020-12-31: $1.92B2021-12-31: $2.02B2022-12-31: $1.59B2023-12-31: $1.36B2024-12-31: $1.18B2025-12-31: $1.03B$1.03B
2008-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$1.03B-12.7%2026-02-13, From 2025-01-01
2024-12-31$1.18B-12.9%2026-02-13, From 2024-01-01
2023-12-31$1.36B-14.9%2026-02-13, From 2023-01-01
2022-12-31$1.59B-21.1%2025-02-14, From 2022-01-01
2021-12-31$2.02B+5.0%2024-02-15, From 2021-01-01
2020-12-31$1.92B+4.6%2023-02-16, From 2020-01-01
2019-12-31$1.84B-10.1%2022-02-16, From 2019-01-01
2018-12-31$2.04B+15.1%2021-02-11, From 2018-01-01
2017-12-31$1.78B+4.1%2020-02-13, From 2017-01-01
2016-12-31$1.71B-2.9%2019-02-14, From 2016-01-01
2015-12-31$1.76B-15.9%2018-02-16, From 2015-01-01
2014-12-31$2.09B-21.7%2017-02-27, From 2014-01-01
2013-12-31$2.67B+50.1%2016-02-18, From 2013-01-01
2012-12-31$1.78B+27.4%2015-03-02, From 2012-01-01
2011-12-31$1.40Bn/c2014-03-18, From 2011-01-01
2010-12-31$1.26B+16.3%2013-02-27, From 2010-01-01
2009-12-31$1.09B+6.7%2012-02-28, From 2009-01-01
2008-12-31$1.02Bn/a2011-02-23, From 2008-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Nu Skin Enterprises, Inc. (NUS)2025-12-31$1.03B-12.7%
Herbalife Ltd. (HLF)2025-12-31$3.92B+0.9%
Cosmos Health Inc. (COSM)2025-12-31$7.90M+83.1%
DataMeds AI, Inc. (MEDS)2025-12-31-$6.43Mn/m
Cardinal Health Inc (CAH)2026-06-30$9.77B+19.7%
Cencora, Inc. (COR)2025-09-30$11.48B+15.8%
McKesson Corp (MCK)2026-03-31$14.55B+9.2%
Stemtech Corp (STEK)2025-12-31$2.31M-38.0%
HWH International Inc. (ESYN)2025-12-31$459.7K-23.6%

Compare NUS, HLF, COSM, MEDS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗